glucose loading, nonoverlapping FATP2 and preproglucagon mRNA expression, and lack of FATP2 and GLP-1 coimmunolocalization in the intestines
However, several studies suggest a general range for daily intake
doi: 10.3389/fmed.2025.1643415 Received 08 June 2025 Accepted 25 September 2025 Published 14 October 2025 Volume 12 - 2025 Edited by Xin Hu, National Center for Child Health and Development (NCCHD), Japan Reviewed by Hua Miao, Northwest University, China Allan Kardec Barros, Universidade Federal do Maranho, Brazil ChandraShekar Annamalai, MVM College of Allied Health Sciences, India Updates Copyright 2025 Wang, Yuan, Wu and Ou
Nutritional therapies and herbs both improve GLP-1 activity and in many cases correct the numerous underlying contributors to metabolic dysfunction, through improving insulin sensitivity and satiety, supporting microbiome health and mitigating inflammation that can disrupt metabolic function
What lifestyle factors will help maximize outcomes
